Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $28.47, with a market capitalization of 162.24B. The stock trades at a price-to-earnings (P/E) ratio of 38.15 and offers a dividend yield of 5.97%.
On 2026-09-04, Pfizer(PFE) stock traded between a low of $28.38 and a high of $28.70. Shares are currently priced at $28.47, which is +0.3% above the low and -0.8% below the high.
The Pfizer(PFE)'s current trading volume is 6.12M, compared to an average daily volume of 34.07M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.
PFE News
Investing Pfizer’s Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying? Pfizer shareholders are collecting a 6% yield while the stock bleeds value, a...
Pfizer stock has delivered a 25.6% return over the past year, yet the overall valuation checks point to a mixed picture rather than a clear bargain or clear pre...
Medicus Pharma Ltd. (NASDAQ:MDCX) secured on Wednesday an exclusive, sublicensable global license from Pfizer Inc. (NYSE:PFE) to develop, manufacture, and comme...
Analyst ratings
66%
of 29 ratingsMore PFE News
Pfizer’s PFE R&D pipeline is becoming an increasingly important part of the investment story as the company is trying to revive growth after the sharp decline i...
Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the October 23rd expiration. At Stock Options Channel, our YieldBoost formula...
Medicus Pharma (MDCX) on Thursday announced a licensing agreement worth up to $1B with Pfizer (PFE) to jointly develop and commercialize PF-08046031 ("CD228V"),...
Wednesday’s total option volume of 62.0 million contracts resulted in net open interest growth of 5.97 million calls and 4.36 million puts. NVIDIA (NVDA), Broad...
Medicus Pharma Ltd ( (MDCX) ) just unveiled an update. On September 2, 2026, Medicus Pharma Ltd., via Medicus Pharma Inc., entered a co-development and license...
Key Points Pfizer's financial results aren't great, and the company will face important patent cliffs relatively soon. However, the company may have a deep en...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase 1 study called “A PHASE 1 STUDY TO EVALUATE SAFETY,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.